Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
56
GBDC Quote, Financials, Valuation and Earnings
Last price:
$15.07
Seasonality move
:
-1.87%
Day range:
$14.85 - $15.10
52-week range:
$14.05 - $17.72
Dividend yield:
10.95%
P/E ratio:
10.69x
P/S ratio:
11.13x
P/B ratio:
0.99x
Volume:
1.4M
Avg. volume:
1.3M
1-year change:
0.6%
Market cap:
$4B
Revenue:
$272.6M
EPS (TTM):
$1.41
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $66.8M | $349.5M | $165.3M | $284.4M | $272.6M | |
| Revenue Growth (YoY) | -- | 422.89% | -52.71% | 72.09% | -4.17% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $12M | $12.6M | $12.5M | $14.8M | $16.3M | |
| Other Inc / (Exp) | -$18.7M | $13M | $20M | -$43.8M | -$77.9M | |
| Operating Expenses | $12M | $8.6M | $10.6M | $22.2M | -$1.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $54.9M | $340.8M | $154.7M | $262.2M | $274.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $543K | $1.2M | $3.6M | $575K | |
| Net Income to Company | $54.9M | $340.3M | $153.4M | $258.6M | $273.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $54.9M | $340.3M | $153.4M | $258.6M | $273.8M | |
| Basic EPS (Cont. Ops) | $0.37 | $2.03 | $0.90 | $1.52 | $1.36 | |
| Diluted EPS (Cont. Ops) | $0.37 | $2.03 | $0.90 | $1.52 | $1.36 | |
| Weighted Average Basic Share | $148.9M | $168M | $170.7M | $170.3M | $201.3M | |
| Weighted Average Diluted Share | $148.9M | $168M | $170.7M | $170.3M | $201.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $129.7M | $406.6M | $244M | $405.4M | $477.5M | |
| Revenue (Reported) | $66.8M | $349.5M | $165.3M | $284.4M | $272.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $129.7M | $406.6M | $244M | $405.4M | $477.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $98.1M | $66.1M | $6.2M | $109.1M | $94.2M | |
| Revenue Growth (YoY) | -- | -32.66% | -90.62% | 1659.72% | -13.58% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.4M | $3M | $3.2M | $4M | $4.5M | |
| Other Inc / (Exp) | -$4.6M | $7.4M | $3.2M | -$422K | -$29.1M | |
| Operating Expenses | $3.4M | -$6.1M | -$2M | $6M | -$853K | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $94.6M | $72.2M | $8.2M | $103.1M | $95.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $543K | $159K | $1.5M | -$103K | |
| Net Income to Company | $94.6M | $71.6M | $8.1M | $101.6M | $95.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $94.6M | $71.6M | $8.1M | $101.6M | $95.2M | |
| Basic EPS (Cont. Ops) | $0.57 | $0.42 | $0.05 | $0.60 | $0.36 | |
| Diluted EPS (Cont. Ops) | $0.57 | $0.42 | $0.05 | $0.60 | $0.36 | |
| Weighted Average Basic Share | $167.4M | $169.2M | $170.9M | $169.6M | $264.9M | |
| Weighted Average Diluted Share | $167.4M | $169.2M | $170.9M | $169.6M | $264.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $108.2M | $96.6M | $42.5M | $141.7M | $159.3M | |
| Revenue (Reported) | $98.1M | $66.1M | $6.2M | $109.1M | $94.2M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $108.2M | $96.6M | $42.5M | $141.7M | $159.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $66.8M | $345.6M | $161.7M | $280.8M | $272.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $12M | $12.6M | $12.5M | $14.8M | $16.3M | |
| Other Inc / (Exp) | -$18.7M | $13M | $20.5M | -$43.8M | -$77.9M | |
| Operating Expenses | $12M | $4.8M | $7M | $18.6M | -$1.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $54.9M | $340.8M | $154.7M | $262.2M | $274.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $543K | $1.2M | $3.6M | $575K | |
| Net Income to Company | $54.9M | $340.3M | $153.4M | $258.6M | $273.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $54.9M | $340.3M | $153.4M | $258.6M | $273.8M | |
| Basic EPS (Cont. Ops) | $0.18 | $2.02 | $0.90 | $1.52 | $1.41 | |
| Diluted EPS (Cont. Ops) | $0.18 | $2.02 | $0.90 | $1.52 | $1.41 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $129.7M | $410.4M | $247.6M | $409.1M | $477.5M | |
| Revenue (Reported) | $66.8M | $345.6M | $161.7M | $280.8M | $272.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $129.7M | $410.4M | $247.6M | $409.1M | $477.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $345.6M | $161.7M | $280.8M | $272.6M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $12.6M | $12.5M | $14.8M | $16.3M | -- | |
| Other Inc / (Exp) | $13M | $20.5M | -$43.8M | -$77.9M | -- | |
| Operating Expenses | $4.8M | $7M | $18.6M | -$1.8M | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $340.8M | $154.7M | $262.2M | $274.4M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $543K | $1.2M | $3.6M | $575K | -- | |
| Net Income to Company | $340.3M | $153.4M | $258.6M | $273.8M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $340.3M | $153.4M | $258.6M | $273.8M | -- | |
| Basic EPS (Cont. Ops) | $2.02 | $0.90 | $1.52 | $1.41 | -- | |
| Diluted EPS (Cont. Ops) | $2.02 | $0.90 | $1.52 | $1.41 | -- | |
| Weighted Average Basic Share | $672M | $682.7M | $681.3M | $805.2M | -- | |
| Weighted Average Diluted Share | $672M | $682.7M | $681.3M | $805.2M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $410.4M | $247.6M | $409.1M | $477.5M | -- | |
| Revenue (Reported) | $345.6M | $161.7M | $280.8M | $272.6M | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $410.4M | $247.6M | $409.1M | $477.5M | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $25.1M | $181.1M | $124.1M | $69.8M | $131.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $42.7M | $199.5M | $177.3M | $142.8M | $236.9M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $4.2B | $4.9B | $5.5B | $5.5B | $8.3B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.4B | $5.2B | $5.7B | $5.7B | $8.7B | |
| Accounts Payable | $11.9M | $18.6M | $26.7M | $32.3M | $56M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $29.2M | $30.8M | $60.1M | $67.5M | $89.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2B | $2.6B | $3.1B | $3.2B | $4.7B | |
| Common Stock | $167K | $170K | $171K | $170K | $264K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $2.4B | $2.6B | $2.5B | $2.5B | $4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.4B | $2.6B | $2.5B | $2.5B | $4B | |
| Total Liabilities and Equity | $4.4B | $5.2B | $5.7B | $5.7B | $8.7B | |
| Cash and Short Terms | $25.1M | $181.1M | $124.1M | $69.8M | $131.2M | |
| Total Debt | $2B | $2.6B | $3.1B | $3.1B | $4.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $25.1M | $181.1M | $124.1M | $69.8M | $131.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $42.7M | $199.5M | $177.3M | $142.8M | $236.9M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $4.2B | $4.9B | $5.5B | $5.5B | $8.3B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.4B | $5.2B | $5.7B | $5.7B | $8.7B | |
| Accounts Payable | $11.9M | $18.6M | $26.7M | $32.3M | $56M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $29.2M | $30.8M | $60.1M | $67.5M | $89.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2B | $2.6B | $3.1B | $3.2B | $4.7B | |
| Common Stock | $167K | $170K | $171K | $170K | $264K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.4B | $2.6B | $2.5B | $2.5B | $4B | |
| Total Liabilities and Equity | $4.4B | $5.2B | $5.7B | $5.7B | $8.7B | |
| Cash and Short Terms | $25.1M | $181.1M | $124.1M | $69.8M | $131.2M | |
| Total Debt | $2B | $2.6B | $3.1B | $3.1B | $4.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $54.9M | $340.3M | $153.4M | $258.6M | $273.8M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$262K | -$836K | -$2.4M | -$37.3M | $25.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $187.7M | -$306M | -$416.5M | $195.4M | $343.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$136.4M | -$139.1M | -$155.2M | -$191.5M | -$338.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.1B | $3.4B | $1.3B | $652.6M | $2.9B | |
| Long-Term Debt Repaid | -$1.3B | -$2.8B | -$741.2M | -$627.1M | -$2.7B | |
| Repurchase of Common Stock | -$45.5M | -$14.7M | -$36.4M | -$63.8M | -$4.8M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$87.8M | $366.9M | $353.1M | -$235.5M | -$124.2M | |
| Beginning Cash (CF) | $84.2M | $184.4M | $244.3M | $180.6M | $140.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $99.9M | $60.8M | -$63.3M | -$40.2M | $219.7M | |
| Ending Cash (CF) | $184.4M | $244.3M | $180.6M | $140.2M | $359.6M | |
| Levered Free Cash Flow | $187.7M | -$306M | -$416.5M | $195.4M | $343.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $94.6M | $71.6M | $8.1M | $101.6M | $95.2M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $1.1M | -$1.2M | -$225K | -$28.1M | $16.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $102.1M | -$386.7M | $158.9M | $64.1M | -$200M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$33.7M | -$35.9M | -$40.2M | -$56.2M | -$139M | |
| Special Dividend Paid | -- | -- | -- | $40K | $50K | |
| Long-Term Debt Issued | $306.2M | $962.3M | $98.5M | $138.7M | $962M | |
| Long-Term Debt Repaid | -$293.5M | -$524.8M | -$146.3M | -$163.3M | -$719M | |
| Repurchase of Common Stock | -$14.8M | -- | -$11M | -$13.5M | -$4.8M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$37.9M | $396.9M | -$99.4M | -$94.7M | $93.7M | |
| Beginning Cash (CF) | $120.1M | $234.8M | $121.2M | $171M | $464.7M | |
| Foreign Exchange Rate Adjustment | $81K | -$660K | -$156K | -$264K | $1.2M | |
| Additions / Reductions | $64.3M | $10.2M | $59.5M | -$30.6M | -$106.4M | |
| Ending Cash (CF) | $184.4M | $244.3M | $180.6M | $140.2M | $359.6M | |
| Levered Free Cash Flow | $102.1M | -$386.7M | $158.9M | $64.1M | -$200M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $54.9M | $340.3M | $153.4M | $258.6M | $273.8M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$262K | -$836K | -$2.4M | -$37.3M | $25.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $187.7M | -$306M | -$416.5M | $195.4M | $343.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$136.4M | -$139.1M | -$155.2M | -$191.5M | -$338.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.1B | $3.4B | $1.3B | $652.6M | $2.9B | |
| Long-Term Debt Repaid | -$1.3B | -$2.8B | -$741.2M | -$627.1M | -$2.7B | |
| Repurchase of Common Stock | -$45.5M | -$14.7M | -$36.4M | -$63.8M | -$4.8M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$87.8M | $366.9M | $353.1M | -$235.5M | -$124.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $99.9M | $60.8M | -$63.3M | -$40.2M | $219.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $187.7M | -$306M | -$416.5M | $195.4M | $343.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $340.3M | $153.4M | $258.6M | $273.8M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$836K | -$2.4M | -$37.3M | $25.1M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$306M | -$416.5M | $195.4M | $343.9M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$139.1M | -$155.2M | -$191.5M | -$338.2M | -- | |
| Special Dividend Paid | -- | -- | $40K | $300K | -- | |
| Long-Term Debt Issued | $3.4B | $1.3B | $652.6M | $2.9B | -- | |
| Long-Term Debt Repaid | -$2.8B | -$741.2M | -$627.1M | -$2.7B | -- | |
| Repurchase of Common Stock | -$14.7M | -$36.4M | -$63.8M | -$4.8M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $366.9M | $353.1M | -$235.5M | -$124.2M | -- | |
| Beginning Cash (CF) | $874.5M | $841.3M | $655.3M | $1.2B | -- | |
| Foreign Exchange Rate Adjustment | -$889K | -$458K | -$171K | -$331K | -- | |
| Additions / Reductions | $60.8M | -$63.3M | -$40.2M | $219.7M | -- | |
| Ending Cash (CF) | $934.4M | $777.5M | $615M | $1.5B | -- | |
| Levered Free Cash Flow | -$306M | -$416.5M | $195.4M | $343.9M | -- | |
Get GBDC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GBDC
Sector
P/E ratio
10.69x
11.99x
PEG ratio
0.13x
0.36x
P/B ratio
0.99x
1.05x
Price / LTM sales
11.13x
2.55x
Growth Metrics
GBDC
Sector
Revenue growth
-13.58%
6.08%
Earnings growth
-40%
6.45%
Revenue (5-year growth)
26.55%
5.85%
Earnings forecast
$0.44
$0.56
Profitability
GBDC
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
4.01%
5.27%
Return on assets
3.96%
0.98%
Return on equity
8.68%
9.43%
Earnings Date
Last Earnings Date
Nov
19
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Feb
18
Balance Sheet
GBDC
Sector
Total cash
$131.2M
$615.3M
Short term investments
--
$408.4M
Total assets
$8.7B
$4.5B
Long term debt
$4.6B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
